← Leaderboards
Sylvia Irene Becker-Dreps
Univ Of North Carolina Chapel Hill
$6,953,062
Attributed
$10,536,020
Total exposure
13
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2009–25$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,536,020 · 13
By mechanism
R01$4,085,439 · 2
R21$2,870,539 · 7
D43$1,354,138 · 1
K24$1,240,629 · 1
K01$507,037 · 1
R56$478,238 · 1
Top collaborators
- Jan Vinje5 shared
- Filemon Bucardo4 shared
- Sean A Diehl4 shared
- Steven Richard Meshnick3 shared
- Diva Mirella Barrientos2 shared
- Natalie Mccarter Bowman2 shared
- Amy K Connery2 shared
- Daniel Olson2 shared
Most similar at Univ Of North Carolina Chapel Hill
Same institution · by research overlap
- Jan Vinje$1,738,818
- Diva Mirella Barrientos$202,601
- Amy K Connery$202,601
Others in their field
Top investigators on “Childhood”
- Gregory H Reaman · National Childhood Cancer Foundation$268,060,146
- Barbara Driver · Westat, Inc.$206,410,885
- Sharon A Nachman · Johns Hopkins University$191,166,598
- Peter C Adamson · National Childhood Cancer Foundation$190,988,407
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$187,267,729
- James E. Gern · University Of Wisconsin-Madison$149,875,125
Research focus
ChildhoodNicaraguaChildFutureSamplingCohortIncidenceDiarrheaAntibodiesGenotypeResearch PersonnelNicaraguanPatternUniversitiesEpidemiologyInfectionLifeVaccinesInfantImmunityBirthRotavirus VaccinesBurden Of IllnessSerum
Grant awards (38)
The INICIO-Guatemala Study: Improving Neurodevelopment with an Intestinal Health and Caregiversâ Intervention in the Occidente, Guatemala$504,248
R01 · FY2025 · HD · contact PI
Advancing the development of tools to better understand humoral responses to sapovirus following natural infections$427,625
R21 · FY2025 · AI · contact PI
Understanding protection against norovirus at the maternal-child interface$198,174
K24 · FY2025 · AI · contact PI
Norovirus immunity at the maternal-child interface$168,740
R21 · FY2025 · AI · contact PI
The INICIO-Guatemala Study: Improving Neurodevelopment with an Intestinal Health and Caregiversâ Intervention in the Occidente, Guatemala$103,555
R01 · FY2025 · HD · contact PI
Norovirus immunity at the maternal-child interface$240,580
R21 · FY2024 · AI · contact PI
Understanding protection against norovirus at the maternal-child interface$198,894
K24 · FY2024 · AI · contact PI
Mucosal immunity to sapovirus in early childhood$193,513
R21 · FY2024 · AI · contact PI
Mucosal immunity to sapovirus in early childhood$246,263
R21 · FY2023 · AI · contact PI
The Development of Norovirus Immunity in Early Childhood and Implications for Norovirus Vaccines$168,367
K24 · FY2023 · AI · contact PI
Nicaraguan Emerging and Endemic Diseases (NEED) Training Program$136,400
D43 · FY2023 · TW · contact PI
Nicaraguan Emerging and Endemic Diseases (NEED) Training Program$236,944
D43 · FY2022 · TW · contact PI
The Development of Norovirus Immunity in Early Childhood and Implications for Norovirus Vaccines$167,511
K24 · FY2022 · AI · contact PI
Nicaraguan Emerging and Endemic Diseases (NEED) Training Program$246,005
D43 · FY2021 · TW · contact PI
Determinants of humoral immunity to norovirus in children$194,575
R21 · FY2021 · AI · contact PI
The Development of Norovirus Immunity in Early Childhood and Implications for Norovirus Vaccines$168,497
K24 · FY2021 · AI · contact PI
Natural history, immunity, and transmission patterns of sapovirus in a Nicaraguan birth cohort$741,394
R01 · FY2020 · AI · contact PI
Determinants of humoral immunity to norovirus in children$247,425
R21 · FY2020 · AI · contact PI
Nicaraguan Emerging and Endemic Diseases (NEED) Training Program$246,161
D43 · FY2020 · TW · contact PI
The Development of Norovirus Immunity in Early Childhood and Implications for Norovirus Vaccines$169,668
K24 · FY2020 · AI · contact PI
Implications of Congenital Zika Virus Infection$148,865
R21 · FY2020 · AI
Natural history, immunity, and transmission patterns of sapovirus in a Nicaraguan birth cohort$774,235
R01 · FY2019 · AI · contact PI
Nicaraguan Emerging and Endemic Diseases (NEED) Training Program$243,478
D43 · FY2019 · TW · contact PI
Implications of Congenital Zika Virus Infection$205,653
R21 · FY2019 · AI
The Development of Norovirus Immunity in Early Childhood and Implications for Norovirus Vaccines$169,518
K24 · FY2019 · AI · contact PI
Natural history, immunity, and transmission patterns of sapovirus in a Nicaraguan birth cohort$661,085
R01 · FY2018 · AI · contact PI
Nicaraguan Emerging and Endemic Diseases (NEED) Training Program$245,150
D43 · FY2018 · TW · contact PI
Zika virus in the human genital tract and implications for transmission$171,432
R21 · FY2018 · AI · contact PI
Natural history, immunity, and transmission patterns of sapovirus in a Nicaraguan birth cohort$685,837
R01 · FY2017 · AI · contact PI
Zika virus in the human genital tract and implications for transmission$207,868
R21 · FY2017 · AI · contact PI
Natural history, immunity, and transmission patterns of sapovirus in a Nicaraguan birth cohort$615,085
R01 · FY2016 · AI · contact PI
Effectiveness and Safety of Tdap Immunization in Pregnancy$190,000
R21 · FY2016 · AI · contact PI
Effectiveness and Safety of Tdap Immunization in Pregnancy$228,000
R21 · FY2015 · AI · contact PI
Simple interventions to Improve Rotavirus Vaccine Effectiveness (SIRVE)$478,238
R56 · FY2014 · AI · contact PI
Preliminary Effectiveness Analysis of Universal Rotavirus Immunization, Nicaragua$126,201
K01 · FY2012 · TW · contact PI
Preliminary Effectiveness Analysis of Universal Rotavirus Immunization, Nicaragua$126,201
K01 · FY2011 · TW · contact PI
Preliminary Effectiveness Analysis of Universal Rotavirus Immunization, Nicaragua$127,373
K01 · FY2010 · TW · contact PI
Preliminary Effectiveness Analysis of Universal Rotavirus Immunization, Nicaragua$127,262
K01 · FY2009 · TW · contact PI